Oval Park Capital is an early-stage venture capital firm that employs a "contrarian investment strategy," focusing on breakthrough physical and industrial technology startups in large global industries traditionally underserved by mainstream venture capital, particularly outside Silicon Valley and in the Southeastern U.S.. They adopt an "early and active" approach, partnering deeply with founders from day one to accelerate growth and build industry-leading businesses, often as the first institutional investor in seed-stage companies.
50% of their portfolio is in AI. Their most common stage is series-a (50% of deals).
Portfolio
4
Fund Size
$40M
Top Stage
Series A
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Lemurian Labs | Series A | $28M | Dec 2025 |
 Medicom | Unknown | — | Jul 2024 |
 Grubbly Farms | Series A | — | Nov 2023 |
| Lemurian Labs | Seed | $9M | Oct 2023 |
Top Co-Investors
Pebblebed1 shared
Uncorrelated Ventures1 shared
Origin Ventures1 shared
Blackhorn Ventures1 shared
Flourish Ventures1 shared
Animal Capital1 shared
Silicon Catalyst Ventures1 shared
Good Growth Capital1 shared
Raptor Group1 shared
Alumni Ventures Group1 shared
UPMC Enterprises1 shared
Cone Health1 shared
Grayhawk Capital1 shared
Triangle Tweener Fund1 shared
Last updated: 16 April 2026